STOCK TITAN

SCYNEXIS (SCYX) 424B Filings

SCYX NASDAQ

Here are the 424B prospectus supplements from SCYNEXIS, Inc. (SCYX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow SCYX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SCYX filings page.

Rhea-AI Summary

SCYNEXIS, Inc. filed a prospectus for the resale of up to 87,000,000 shares of Common Stock by the selling stockholders. The 87,000,000 shares comprise 34,750,000 outstanding shares, 8,750,000 Pre-Funded Warrant shares and 43,500,000 Common Warrant shares.

The company will not receive proceeds from these resales, except for cash exercises of the Pre-Funded Warrants at $0.0001 per share and Common Warrants at $1.20 per share. The shares were issued in a March 30, 2026 private placement at purchase prices of $0.92 per share with accompanying warrants and $0.9199 per Pre-Funded Warrant with accompanying warrants. The registration was filed to satisfy registration rights in the Purchase Agreement and related Registration Rights Agreement.